Navigation Links
Deadline Approaches for ISPE Drug Shortage Survey
Date:3/13/2013

TAMPA, Fla., March 13, 2013 /PRNewswire-USNewswire/ -- ISPE announced today that the deadline is approaching for pharmaceutical professionals and companies to participate in the Society's global survey on drug shortages. Responses to the survey are due by 20 March 2013.

(Logo: http://photos.prnewswire.com/prnh/20120912/DC73253LOGO)

ISPE initially announced the survey in mid-February as part of its Drug Shortage Initiative, a global effort led by a task force of industry leaders with review and input by leading global health authorities and related organizations. ISPE launched this initiative in support of the pharmaceutical industry and global health authorities' efforts to understand and address the complex and critical issue of drug shortages. The survey is designed to collect data on the technical, scientific, manufacturing, quality and compliance issues that may have resulted in drug shortages.

"We are reaching out to pharmaceutical professionals and ISPE Members who have had experience dealing with technical, quality and manufacturing issues related to drug shortages, as well as those who have worked to avoid a shortage or who have never experienced a shortage but have been personally affected by a shortage situation," said ISPE President and CEO Nancy S. Berg . "This much-needed technical data will yield new insights into a critical global health issue."

ISPE is encouraging responses from both individuals and companies. Survey responses will be completely anonymous, and all data will be tabulated by a third-party firm. Results are expected to be announced and discussed at ISPE's Redefining the "C" in "CGMP" Conference in Baltimore, Md. USA, 11 – 13 June 2013.

For more information on this important initiative, please visit www.ISPE.org/DrugSurveyDetails.

About ISPE

ISPE, the International Society for Pharmaceutical Engineering, is the world's largest not-for-profit association serving its Members through leading scientific, technical and regulatory advancement throughout the entire pharmaceutical lifecycle. The 20,000 Members of ISPE are building solutions in the development and manufacture of safe and effective pharmaceutical and biologic medicines and medical delivery devices in more than 90 countries around the world. Founded in 1980, ISPE has its worldwide headquarters in Tampa, Florida, USA and offices in Brussels, Belgium, Singapore and Shanghai, China. Visit www.ISPE.org for more information.

For more information contact:

Danielle Hould
ISPE Communications Manager
Tel: +1-813-960-2105, ext. 277
email: dhould@ispe.org
www.ISPE.org  


'/>"/>
SOURCE ISPE
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Obama Victory Reinforces Need for Insurers to Prepare for Healthcare Exchange 2013 and 2014 Deadlines
2. As Deadline Approaches, Practice Fusion Shares Meaningful Use Stories
3. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing In American Oriental Bioengineering Inc. To Contact The Firm Regarding The August 22, 2012 Lead Plaintiff Deadline
4. Berger & Montague, P.C. Reminds Viropharma Shareholders That The Deadline To Petition The Court To Act As Lead Plaintiff Is July 23, 2012
5. Developers: Deadline Approaching for Allscripts Million Hearts CDS Challenge
6. Faruqi & Faruqi, LLP Notifies Investors of June 4, 2012 Lead Plaintiff Deadline for the Class Action Filed Against Chelsea Therapeutics International
7. Janssen Neuroscientists and Colleagues Challenge Healthcare Industry to Create Integrated Approaches to Healthcare Innovation in Newly Published Article
8. Businessmen Bank on Marijuana as Colorados Green Rush Approaches in the Medical Marijuana Industry with Hemp, Inc. (OTC: HEMP) Leading the Charge
9. As Prescription Painkiller Overdoses Mount, Researchers Outline Effective Approaches to Curb Epidemic
10. Cook Medical, Zimmer, Pro-Dex & J&J to Share Innovative Social Media Approaches to Marketing Device Products in Minneapolis
11. Survey of Oncologists Reveals 98.9% of Physicians Experienced Cancer Drug Shortages in Last 12 Months
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... April 29, 2016 ... Financier Sanofi, leader mondial ... ses résultats pour le premier trimestre ... Jérôme Contamine, commente les résultats du ... perspectives pour le reste de l,année. ...
(Date:4/28/2016)... April 28, 2016   Click here for ... Inc. (NYSE: DPLO), the nation,s largest independent specialty ... definitive agreement to acquire Valley Campus Pharmacy, Inc., ... a leading specialty pharmacy that provides individualized patient ... . In 2015, TNH generated approximately $400 ...
(Date:4/28/2016)... , April 28, 2016  Marking its one ... breast and ovarian cancer risk test, Color ... 30 genes that highly impact the most common ... today, the Color Test analyzes hereditary cancer risks ... and uterine cancers. The Color Test is physician ...
Breaking Medicine Technology:
(Date:4/30/2016)... ... April 30, 2016 , ... ... and recognize veterinarians’ global impact on public health. The World Veterinary Association (WVA) ... and this year have selected continuing education with a One Health focus, which ...
(Date:4/29/2016)... ... April 30, 2016 , ... ... patented products, announces the Pick Up Springboard, an automotive invention that improves the ... Manufacturing industry is worth $162 billion," says Scott Cooper, CEO and Creative Director ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... Awakening , announces the addition Onnit brand Alpha BRAIN and New Mood Daily-Stress ... Onnit brain and mood optimization products to the store is just one more ...
(Date:4/29/2016)... ... April 29, 2016 , ... The White House ... their loans, more information about their loan terms and accounts, and more protections ... debt, including federal and private loans, has reached $1.3 trillion, with 43 million ...
(Date:4/29/2016)... ... April 29, 2016 , ... The Wharton School of ... Grand Prize of the 2016 Wharton Business Plan Competition —as well as ... Award, and the Committee Award for Most ‘Wow Factor,’ making them the first ...
Breaking Medicine News(10 mins):